"The US Food and Drug Administration (FDA) has approved a fixed-dose combination of memantine hydrochloride extended-release (XR) and donepezil hydrochloride (Namzaric, Actavis plc/Adamas Pharm) for moderate to severe Alzheimer's-related de"...
Instruct patients to inform their healthcare provider if they:
- are pregnant or breast feeding, or
- have had prior reactions to Vizamyl or any component, including polysorbate 80, or
- have reduced renal or hepatic function
Instruct patients to increase their level of hydration before and after receiving Vizamyl (Flutemetamol F 18 Injection) and to void frequently for the first 24 hours following Vizamyl administration.
Last reviewed on RxList: 12/18/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Vizamyl Information
Report Problems to the Food and Drug Administration
Get breaking medical news.